相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy
Helena Oehrvik et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2015)
Organoiridium Complexes: Anticancer Agents and Catalysts
Zhe Liu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
Francesco Tadini-Buoninsegni et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Metallodrugs in Medicinal Inorganic Chemistry
Katja Dralle Mjos et al.
CHEMICAL REVIEWS (2014)
A golden future in medicinal inorganic chemistry: the promise of anticancer gold organometallic compounds
Benoit Bertrand et al.
DALTON TRANSACTIONS (2014)
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer
Eric S. Kim et al.
LUNG CANCER (2014)
Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand
Vojtech Novohradsky et al.
METALLOMICS (2014)
Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast Neoplasia
Chiara Nardon et al.
PLOS ONE (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium
K. M. Hillgren et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Transition metal bioconjugates with an organometallic link between the metal and the biomolecular scaffold
Angele Monney et al.
COORDINATION CHEMISTRY REVIEWS (2013)
Emerging protein targets for metal-based pharmaceutical agents: An update
Andreia de Almeida et al.
COORDINATION CHEMISTRY REVIEWS (2013)
N-Heterocyclic carbene metal complexes in medicinal chemistry
Luciano Oehninger et al.
DALTON TRANSACTIONS (2013)
Contribution of intracellular ATP to cisplatin resistance of tumor cells
Verena Schneider et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
ATP11B mediates platinum resistance in ovarian cancer
Myrthala Moreno-Smith et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs)
Qing Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
A Decade of the Human Genome SequenceuHow Does the Medicinal Chemist Benefit?
Andreas Brunschweiger et al.
CHEMMEDCHEM (2012)
Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients
Xiaojing Xu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2012)
Gold(I)-NHC complexes of antitumoral diarylimidazoles: Structures, cellular uptake routes and anticancer activities
Leonard Kaps et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Toward the Selective Delivery of Chemotherapeutics into Tumor Cells by Targeting Peptide Transporters: Tailored Gold-Based Anticancer Peptidomimetics
Morelle Negom Kouodom et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells
Qing Li et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Overcoming Platinum Resistance through the Use of a Copper-Lowering Agent
Siqing Fu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
Zheng D. Liang et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes
Isolda Romero-Canelon et al.
METALLOMICS (2012)
P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation
Lenka Gibalova et al.
TOXICOLOGY IN VITRO (2012)
Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)
Xinghao Wang et al.
CHEMICAL SCIENCE (2012)
Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry?
Angela Casini et al.
CHEMICAL SCIENCE (2012)
Membrane Transporters as Mediators of Cisplatin Effects and Side Effects
Giuliano Ciarimboli
SCIENTIFICA (2012)
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
Atsushi Yonezawa et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Molecular Mechanisms and Proposed Targets for Selected Anticancer Gold Compounds
Angela Casini et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties
Elena Vergara et al.
DALTON TRANSACTIONS (2011)
Drug transporters of platinum-based anticancer agents and their clinical significance
Herman Burger et al.
DRUG RESISTANCE UPDATES (2011)
Comparative in Vitro Evaluation of N-Heterocyclic Carbene Gold(I) Complexes of the Benzimidazolylidene Type
Riccardo Rubbiani et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Organometallic Anticancer Compounds
Gilles Gasser et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Organometallic ruthenium-based antitumor compounds with novel modes of action
Wee Han Ang et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2011)
Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions
Giuliano Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Protecting Cisplatin-Induced Nephrotoxicity with Cimetidine Does Not Affect Antitumor Activity
Hiromu Katsuda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2010)
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial J. Wheate et al.
DALTON TRANSACTIONS (2010)
Copper Transporters and the Cellular Pharmacology of the Platinum-Containing Cancer Drugs
Stephen B. Howell et al.
MOLECULAR PHARMACOLOGY (2010)
Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies
Inge A. M. de Graaf et al.
NATURE PROTOCOLS (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1
Sarah E. Crider et al.
METALLOMICS (2010)
Role of copper transporters in resistance to platinating agents
Cara A. Rabik et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Structural Biology of Copper Trafficking
Amie K. Boal et al.
CHEMICAL REVIEWS (2009)
Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Lingegowda S. Mangala et al.
CLINICAL CANCER RESEARCH (2009)
On the medicinal chemistry of gold complexes as anticancer drugs
Ingo Ott
COORDINATION CHEMISTRY REVIEWS (2009)
The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes
Luca Ronconi et al.
DALTON TRANSACTIONS (2009)
Groundbreaking gold(III) anticancer agents
Dolores Fregona et al.
DRUG DISCOVERY TODAY (2009)
Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin-based chemotherapy
Eva Martinez-Balibrea et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
Zhengyi Wu et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
Crystal Structures of Cisplatin Bound to a Human Copper Chaperone
Amie K. Boal et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
From delocalized lipophilic cations to hypoxia: Blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors
Metin Kurtoglu et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity
Navjotsingh Pabla et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
Matthew D. Hall et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
The design of gold-based, mitochondria-targeted chemotherapeutics
Susan J. Berners-Price et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2008)
Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer Agents
Anna F. A. Peacock et al.
CHEMISTRY-AN ASIAN JOURNAL (2008)
Carbohydrate-Metal Complexes and their Potential as Anticancer Agents
Christian G. Hartinger et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
Sachiko Yokoo et al.
DRUG METABOLISM AND DISPOSITION (2008)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: New insights from X-ray diffraction and mass spectrometry studies
Angela Casini et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium (II)-Arene Compounds
Angela Casini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1
Helen H. W. Chen et al.
MOLECULAR PHARMACOLOGY (2008)
Opinion - Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
Paul D. Dobson et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Peptide transporters and their roles in physiological processes and drug disposition
I. Rubio-Aliaga et al.
XENOBIOTICA (2008)
Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity
Sachiko Yokoo et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Organometallic analogues of tamoxifen:: Effect of the amino side-chain replacement by a carbonyl ferrocenyl moiety in hydroxytamoxifen
Anh Nguyen et al.
JOURNAL OF ORGANOMETALLIC CHEMISTRY (2007)
Ruthenium complexes can target determinants of tumour malignancy
A. Bergamo et al.
DALTON TRANSACTIONS (2007)
Interaction between platinum complexes and a methionine motif found in copper transport proteins
Fabio Arnesano et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Gold(I) chloride adducts of 1,3-bis(di-2-pyridylphosphino) propane: synthesis, structural studies and antitumour activity
Anthony S. Humphreys et al.
DALTON TRANSACTIONS (2007)
The roles of copper transporters in cisplatin resistance
Macus Tien Kuo et al.
CANCER AND METASTASIS REVIEWS (2007)
The internalization and degradation of human copper transporter 1 following cisplatin exposure
Alison K. Holzer et al.
CANCER RESEARCH (2006)
Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)
Atsushi Yonezawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin
Alison K. Holzer et al.
MOLECULAR PHARMACOLOGY (2006)
Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology
Andrei R. Timerbaev et al.
CHEMICAL REVIEWS (2006)
Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2
G Ciarimboli et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Sodium-dependent glucose transporter reduces peroxynitrite and cell injury caused by cisplatin in renal tubular epithelial cells
A Ikari et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2005)
A predictive model for the selective accumulation of chemicals in tumor cells
S Trapp et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2005)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology
MF Ross et al.
BIOCHEMISTRY-MOSCOW (2005)
Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (FFC14A)
P Heffeter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes
YK Yan et al.
CHEMICAL COMMUNICATIONS (2005)
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins - Introduction
MA Hediger et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells
AK Holzer et al.
CLINICAL CANCER RESEARCH (2004)
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells
AK Holzer et al.
MOLECULAR PHARMACOLOGY (2004)
Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells
GL Beretta et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B
G Samimi et al.
MOLECULAR PHARMACOLOGY (2004)
Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter - Requirement for the extracellular methionine-rich clusters
Y Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of copper transporters in the development of resistance to Pt drugs
R Safaei et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Strategies for reversing drug resistance
T Fojo et al.
ONCOGENE (2003)
The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells
K Katano et al.
MOLECULAR PHARMACOLOGY (2003)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake
S Puig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Transferrin/transferrin receptor-mediated drug delivery
HY Li et al.
MEDICINAL RESEARCH REVIEWS (2002)
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
JS Modica-Napolitano et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
The molecular basis of copper-transport diseases
JFB Mercer
TRENDS IN MOLECULAR MEDICINE (2001)
分享论文
